This page is optimized for a taller screen. Please rotate your device or increase the size of your browser window.

Economic Evaluation of Sorafenib versus Best Supportive Care in AdvancedRenal Cell Carcinoma: An Updated Cost-Effectiveness Analysis

Xin Gao, Sonalee Shah, Prabashni Reddy, Kathleen Gondek, Chris L Pashos


June 1, 2008
Focus Areas